Position in OVID
as of Jun 30, 2026
· filed Aug 14, 2026
Position Value
$338,200
+$332,773 QoQ
Shares Held
125,725
+622.7% QoQ
Ownership
0.064%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#51
of 130 holders
Holding Since
Mar 2021
18 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in OVID Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026PRICE T ROWE ASSOCIATES INC /MD/ holds $17,555,962,932 across 304 Biotechnology names. OVID ranks #224 (0.0% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | ARGX |
Argenx SE
|
2,678,047 | $2,484,611,664 | |
| 2 | REGN |
Regeneron Pharmaceuticals, Inc.
|
1,529,709 | $953,834,749 | |
| 3 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
1,728,421 | $858,558,562 | |
| 4 | KYMR |
Kymera Therapeutics, Inc.
|
7,112,980 | $815,645,416 | |
| 5 | RPRX |
Royalty Pharma plc
|
11,193,657 | $627,628,347 | |
| 6 | RVMD |
Revolution Medicines, Inc.
|
2,969,853 | $447,655,945 | |
| 7 | MRNA |
Moderna, Inc.
|
5,589,560 | $391,436,886 | |
| 8 | SRRK |
Scholar Rock Holding Corp
|
6,794,837 | $373,716,035 |
All Filings in OVID
Export CSV
18 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $338,200 | 125,725 | Shares | Defined | 2026-08-14 | |
| 2025-03-31 | $5,427 | 17,396 | Shares | Defined | 2025-05-14 | |
| 2024-12-31 | $16,247 | 17,396 | Shares | Defined | 2025-02-14 | |
| 2024-09-30 | $20,527 | 17,396 | Shares | Defined | 2024-11-14 | |
| 2024-06-30 | $13,377 | 17,396 | Shares | Defined | 2024-08-14 | |
| 2024-03-31 | $53,057 | 17,396 | Shares | Defined | 2024-05-15 | |
| 2023-12-31 | $45,888 | 14,251 | Shares | Defined | 2024-02-16 | |
| 2023-09-30 | $51,509 | 13,414 | Shares | Defined | 2023-11-14 | |
| 2023-06-30 | $39,730 | 12,113 | Shares | Defined | 2023-08-14 | |
| 2023-03-31 | $70,950 | 27,500 | Shares | Defined | 2023-05-15 | |
| 2022-12-31 | $51,150 | 27,500 | Shares | Defined | 2023-02-14 | |
| 2022-09-30 | $50,600 | 27,500 | Shares | Defined | 2022-11-14 | |
| 2022-06-30 | $66,935 | 31,133 | Shares | Sole | 2022-08-15 | |
| 2022-03-31 | $119,197 | 37,961 | Shares | Sole | 2022-05-16 | |
| 2021-12-31 | $121,854 | 37,961 | Shares | Sole | 2022-02-14 | |
| 2021-09-30 | $127,548 | 37,961 | Shares | Sole | 2021-11-15 | |
| 2021-06-30 | $148,427 | 37,961 | Shares | Sole | 2021-08-16 | |
| 2021-03-31 | $147,726 | 36,748 | Shares | Sole | 2021-05-17 | |
| No filing history on record for this holder in this stock. | ||||||